![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 24, 18114-18120, June 16, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Cell Biology and Physiology, Washington
University School of Medicine, St. Louis, Missouri 63110
Received for publication, March 8, 2000, and in revised form, April 4, 2000
Osmotic shock can cause insulin resistance in
3T3-L1 adipocytes by inhibiting insulin activation of glucose
transport, p70S6 kinase, glycogen synthesis, and lipogenesis. By
further investigating the relationship between insulin and hypertonic
stress, we have discovered that osmotic shock enhanced by 10-fold the
insulin-stimulated tyrosine phosphorylation of a 68-kDa protein.
Phosphorylation by insulin was maximal after 1 min and was saturated
with 50-100 nM insulin. The effect of sorbitol was
completely reversible by 2.5 min. pp68 was a peripheral protein that
was localized to the detergent insoluble fraction of the low density
microsomes but was not associated with the cytoskeleton. Stimulation of
the p42/44 and the p38 MAP kinase pathways by osmotic shock had no
effect on pp68 phosphorylation. Treatment of adipocytes with the
phosphotyrosine phosphatase inhibitor phenylarsine oxide also enhanced
insulin-activated tyrosine phosphorylation of pp68 suggesting that
osmotic shock may increase pp68 phosphorylation by inhibiting a
phosphotyrosine phosphatase. Dissociation of pp68 from the low density
microsomes with RNase A indicated that pp68 binds to RNA. Failure to
immunoprecipitate pp68 using antibodies directed against known
60-70-kDa tyrosine-phosphorylated proteins suggest that pp68 may be a
novel cellular target that lies downstream of the insulin receptor.
The metabolic and mitogenic effects of insulin are initiated by
the binding of the hormone to specific cell surface receptors that
results in the autophosphorylation of critical tyrosine residues, which
then activates an intrinsic tyrosine kinase (1). Insulin receptor
substrate-1 (IRS-1)1 and SHC,
the two best characterized substrates of the insulin receptor tyrosine
kinase, serve as docking sites for various SH2 domain-containing
proteins to generate multiple independent cellular signals that
ultimately lead to various downstream biological responses (2, 3).
Tyrosine-phosphorylated IRS-1 is known to bind to two regulatory
subunits of PI 3-kinase, p85 and p55, Grb2, the tyrosine phosphatase
Syp, Fyn, Nck, and Crk (4-6). PI 3-kinase has been implicated in a
wide variety of insulin effects that include stimulation of glucose
transport through the translocation of Glut 4 to the cell surface,
activation of glycogen synthesis, inhibition of lipolysis, and
induction of membrane ruffling (7). SHC can also bind to Grb2 (8), and
through its interaction with mSOS it can cause Ras activation and
subsequent increased mitogensis (9).
Osmotic shock has been shown to increase glucose uptake in 3T3-L1
adipocytes by stimulating the translocation of Glut 4 to the cell
surface (10). The signal transduction pathway is distinct from insulin
in that it fails to activate PI 3-kinase or AKT. Interestingly,
treatment of cells with the tyrosine kinase inhibitor genistein or
microinjection of phosphotyrosine antibodies blocks both insulin and
sorbitol-induced Glut 4 translocation, suggesting a tyrosine kinase
signaling cascade is important for both pathways. The stimuli are not
additive. Furthermore, a subsequent study showed that pretreatment with
600 mM sorbitol inhibits insulin from further increasing
glucose transport (11). Although early insulin signaling such as
insulin receptor autophosphorylation, tyrosine phosphorylation of
IRS-1, and activation of PI 3-kinase are normal, osmotic stress
inhibits insulin activation of AKT by stimulating a phosphatase that
maintains Thr308 and Ser473 of AKT in the
dephosphorylated state. Activation of a similar or identical
phosphatase may be responsible for the inhibition of both basal and
insulin-stimulated p70S6 kinase activities by hypertonic shock (12).
Pretreatment with the phosphatase inhibitors okadaic acid or calyculin
A prevents the inhibition of insulin activation of AKT (11) and the
deactivation of p70S6 kinase (12). It is not known whether sorbitol
activates the phosphatase through an intrinsic activation mechanism or
by altering the subcellular localization of the enzyme or substrate.
In the present study we further investigate the effects of osmotic
shock on insulin action. Pretreatment of 3T3-L1 adipocytes with 600 mM sorbitol enhances by 10-fold the insulin-stimulated tyrosine phosphorylation of a 68-kDa protein. Additional
characterization indicates that this protein is a peripheral protein
that resides in the detergent-insoluble fraction of low density
microsomes (LDM) by binding to RNA.
Materials--
Cytochalasin D, nocodazole, poly(A)-Sepharose 4B,
and poly(U)-agarose were purchased from Sigma. Latrunculin B was from
BioMol. PD 98059 and SB 203580 were from Calbiochem. Phenylarsine oxide was purchased from Aldrich.
Subcellular Fractionation of 3T3-L1 Adipocytes--
3T3-L1
fibroblasts were grown to confluence and 48 h later subjected to
differentiation as described previously (13). 3T3-L1 adipocytes were
used 10-14 days after differentiation. Cells were washed three times
with phosphate-buffered saline and incubated for at least 2 h to
overnight in serum-free Dulbecco's modified Eagle's medium (DMEM).
Adipocytes were then incubated with DMEM alone or DMEM supplemented
with insulin or sorbitol. After the treatment, cells were washed three
times with ice-cold phosphate-buffered saline, scraped in 2 ml/10-cm
dish of ice-cold HES (255 mM sucrose, 20 mM
HEPES, pH 7.4, and 1 mM EDTA) containing 100 mM
sodium fluoride, 10 mM sodium pyrophosphate, 1 mM sodium vanadate, and protease inhibitors and then
homogenized by passing the cells 10 times through a Yamato LSC
homogenizer at a speed of 1200 rotations/min at 4 °C. Subcellular
fractionation was carried out by differential centrifugation as
described previously (14). The following protease inhibitors were used:
1 µg/ml leupeptin, 1 µg/ml antipain, 1 µg/ml benzamidine, 5 µg/ml trypsin inhibitor, 1 µg/ml chymostatin, 1 µg/ml pepstatin
A, and 0.5 mM phenylmethylsufonyl fluoride.
Western Blot Analysis--
50 µg of protein were subjected to
SDS-polyacrylamide gel electrophoresis and then transferred to
nitrocellulose. Phosphotyrosine-phosphorylated proteins were detected
using the monoclonal PY-20 antibody (Transduction Laboratories).
125I-Labeled goat anti-mouse IgG (0.25 µCi/ml, ICN,
Irvine, CA) was used as the secondary antibody. Radioactive bands were
quantitated by a PhosphoImager SI Analyzer (Molecular Dynamics). The
phospho-specific antibodies, phospho-p42/44 MAP kinase
(Thr202/Tyr204) E10 monoclonal antibody,
phospho-p38 MAP kinase (Thr180/Tyr182)
antibody, and the phospho-SAPK/JNK
(Thr183/Tyr185) antibody, were from New England
Biolabs. Enhanced chemiluminescence was used for the detection.
Immunoprecipitation of Possible Candidate and Interacting
Proteins--
0.5-1.0 mg of LDM were solubilized with 0.5-1 ml of
Buffer A (50 mM HEPES, pH 7.4, 1 mM EDTA, 150 mM NaCl, 1 mM sodium vanadate, 100 mM sodium fluoride, 10 mM sodium pyrophosphate,
1% Triton X-100, and protease inhibitors). After centrifugation for 10 min at 4 °C in a microfuge, the supernatant was incubated overnight with 4 µg of primary antibody. 50 µl of protein A-Sepharose or 50 µl of goat anti-mouse IgG affinity gel (Cappel, ICN) were added for
2 h at 4 °C to the reactions that contained polyclonal or monoclonal primary antibodies, respectively. After washing pellets four
times with ice-cold Buffer A containing detergent and twice with Buffer
A without detergent, proteins were eluted with SDS sample buffer. The
immunoprecipitates were subjected to SDS-polyacrylamide gel
electrophoresis and analyzed by Western blot using PY20
antiphosphotyrosine antibodies as described above. Antibodies directed
against SHC, RasGAP, Paxillin, Sam68, Grb2, and Nck were purchased from
Transduction Laboratories. Cbl, Cas, p62Dok, Fyn, and IRS-3 antibodies
were from Santa Cruz. Fak, PTP1C, Pyk2, Syp, Src, and PI 3-kinase
antibodies were from Upstate Biotechnology. Polyclonal antibodies
directed against Glut 4 transporter and IRS-1 were generated by
immunizing rabbits with peptides corresponding to the final 16 amino
acids of each protein. Determination of whether the
immunoprecipitations were successful was carried out by Western blot
analyses of aliquots of the supernatants before and after immunoprecipitation.
Insulin-induced Tyrosine Phosphorylation of a 68-kDa Protein Is
Increased with Osmotic Shock--
Osmotic shock has been shown to
cause insulin-resistance in 3T3-L1 adipocytes by inhibiting insulin
activation of glucose transport, p70S6 kinase, glycogen synthesis, and
lipogenesis (11). To further investigate the effects of osmotic shock
on insulin action, 3T3-L1 adipocytes were treated for 30 min with
either DMEM alone or DMEM containing 100 nM insulin, 600 mM sorbitol, or the combination of sorbitol and insulin.
The cells were homogenized, fractionated by differential
centrifugation, and then Western blot analyses were conducted on the
various enriched subcellular compartments using a phosphotyrosine
antibody (Fig. 1). As reported previously
(10), insulin but not sorbitol, stimulated the tyrosine autophosphorylation of the insulin receptor (95-kDa band) in the plasma
membrane (PM) fraction. Interestingly, the combination of sorbitol and
insulin actually increased the tyrosine phosphorylation of the insulin
receptor 2-fold compared with cells treated with insulin alone. Western
blots using an insulin receptor antibody showed that the amount of
receptor in the PM was identical for all conditions suggesting that
sorbitol enhanced ligand-induced tyrosine autophosphorylation (data not
shown). Analysis of the cytosol indicated that sorbitol did not affect
insulin-stimulated tyrosine phosphorylation of IRS-1 (165-kDa band).
Sorbitol alone did induce the tyrosine phosphorylation of several
cytosolic proteins in the 115-130 kDa and 50-70 kDa range as was
described previously (10). The LDM fraction is enriched in endosomes,
the Golgi apparatus, as well as insulin-responsive Glut 4-containing
vesicles (15). In addition, tyrosine-phosphorylated IRS-1 has been
shown to bind and activate PI 3-kinase in the LDM (16). Osmotic shock
did not prevent tyrosine-phosphorylated IRS-1 from associating with the
LDM (Fig. 1), nor did it affect IRS-1 from binding and activating PI
3-kinase (data not shown (11)). In addition, sorbitol, but not insulin,
increased the tyrosine phosphorylation of at least one protein in the
115-120-kDa protein range. The most dramatic effect, however, was the
appearance of a 68-kDa protein that was tyrosine-phosphorylated in
response to insulin alone, but not sorbitol, and whose phosphorylation
was increased 6-10-fold when cells were treated with both insulin and
sorbitol. Closer examination of the blot revealed that two additional
proteins (55 and 75 kDa) had greater tyrosine phosphorylation content
when cells were treated with both insulin and sorbitol compared with
insulin alone, although the increases were small relative to that of
pp68. Because the enhancement of pp68 phosphorylation by sorbitol was
apparent from phosphotyrosine blots of whole cell lysates (data not
shown), insulin must stimulate the phosphorylation of this protein
rather than simply altering the subcellular localization of a
sorbitol-induced tyrosine-phosphorylated 68-kDa protein from the
cytosol to the LDM. The high density microsomes are enriched in
endoplasmic reticulum but are also contaminated with organelles in the
PM and LDM fractions (14, 15). The appearance of low levels of both
tyrosine-phosphorylated insulin receptor and pp68 in this fraction
(Fig. 1) is consistent with the cross-contamination. The
mitochondrial/nuclear fraction contained few tyrosine-phosphorylated
proteins (data not shown). Wortmannin had no significant effect on the
tyrosine phosphorylation of any protein in any compartment with the
exception that it reduced the sorbitol-induced phosphorylation of
115-120-kDa proteins in the cytosol and LDM.
Characterization of pp68 Phosphorylation--
Because pp68 was
tyrosine-phosphorylated in response to insulin alone and its
phosphorylation was dramatically elevated with osmotic shock and it was
preferentially found in the LDM fraction, which also contains important
insulin signaling molecules (17), we further characterized the
phosphorylation of this protein. 100 nM insulin was added
for varying periods of time to 3T3-L1 adipocytes that were first
preincubated for 15 min with 600 mM sorbitol.
Antiphosphotyrosine Western blots were then conducted on LDM isolated
by subcellular fractionation. Fig. 2
shows that insulin-induced tyrosine phosphorylation of pp68 was rapid
and complete after 1 min. Although this time frame is consistent with the insulin receptor phosphorylating p68 directly (18), we cannot rule
out the possibility that insulin activates another tyrosine kinase,
which, in turn, phosphorylates p68. Next we measured the insulin
concentration dependence to determine whether the insulin response was
because of the insulin receptor or the insulin-like growth factor-1
receptor (Fig. 2). Varying concentrations of insulin were added for 5 min to cells that were first pretreated for 15 min with 600 mM sorbitol. Tyrosine phosphorylation of pp68 was apparent
with 5 nM insulin and saturated between 50 and 100 nM insulin suggesting that the insulin and not
the insulin-like growth factor-1 receptor was responsible for
stimulating the tyrosine phosphorylation (19).
The effect of sorbitol on pp68 tyrosine phosphorylation was completely
reversible (Fig. 3). Adipocytes were
incubated in 600 mM sorbitol for 15 min followed by the
addition of 100 nM insulin for 5 min. Cells were then
washed and incubated for varying periods of time with DMEM containing
insulin in the absence of sorbitol. The amount of
tyrosine-phosphorylated pp68 in the LDM was quantitated from
phosphotyrosine Western blots. The sorbitol induction of pp68 tyrosine
phosphorylation was reversible and complete by 2.5 min after sorbitol
removal. Maintaining insulin throughout the washout did not prevent the
reversal.
pp68 Is a Peripheral Protein That Associates with the Triton X-100
Insoluble Fraction of the LDM--
Tyrosine-phosphorylated IRS-1 can
be released from the LDM with high salt but not with Triton X-100 (17).
Because of this observation in conjunction with the identification of
filamentous actin in the IRS-1-containing LDM fraction, it was proposed
that phosphorylated IRS-1 may be associated with the actin cytoskeleton (17). To determine the extraction properties of pp68, LDM prepared from
sorbitol- and insulin-treated adipocytes was incubated with either 600 mM NaCl or 1% Triton X-100 for 30 min. The soluble and
insoluble fractions were isolated after centrifugation for 1 h at
200,000 × g. Phosphotyrosine blots on the different
fractions revealed that similarly to tyrosine-phosphorylated IRS-1,
pp68 can be extracted with high salt but not with nonionic detergent (Fig. 4A). Glut 4, on the
other hand, was removed from the LDM with 1% Triton X-100 but not high
salt. Treatment of sorbitol- and insulin-treated cells with either the
actin-depolymerizing agents, cytochalasin D or latrunculin B, or with
the tubulin depolymerizing agent, nocodazole, failed to affect the
levels of tyrosine-phosphorylated pp68 associated with the LDM (Fig.
4B). Although these compounds did not affect pp68
phosphorylation, confocal microscopy revealed that they did
dramatically alter filamentous structures (data not shown).
The p42/44 and the p38 MAP Kinase Pathways Are Not Involved in pp68
Phosphorylation--
Osmotic stress is known to activate the p38 MAP
kinase (20) and SAPK/JNK (21) pathways, and insulin activates the
p42/44 MAP kinases (22). To verify the effects of insulin and sorbitol on these pathways, Western blot analyses were carried out on whole cell
lysates from 3T3-L1 adipocytes that were incubated for 30 min with DMEM
alone or with DMEM containing insulin, sorbitol, or the combination of
insulin and sorbitol using phospho-specific antibodies directed against
the activated forms of p42/44 MAP kinase, p38 MAP kinase, or SAPK/JNK.
Fig. 5A shows that p42/44 MAP
kinases were activated by both insulin and sorbitol and that these
effects were additive in cells incubated with both insulin and sorbitol
for 30 min. Wortmannin inhibited insulin but not sorbitol-induced
activation. Inhibition of insulin activation of p42/44 MAP kinase by
wortmannin has been previously reported in both 3T3-L1 adipocytes (23)
and in skeletal muscle (24). Sorbitol dramatically increased the
phosphorylation of p38 MAP kinase and SAPK/JNK. In agreement with Chen
et al., (10), we saw very little if any effect of insulin on
modulating the phosphorylation of p38 MAP kinase. This observation is
in contrast to another recent report using 3T3-L1 adipocytes (25).
Wortmannin had no effect on the stress-induced phosphorylation of p38
or SAPK/JNK. To address whether the enhancement of insulin-induced
tyrosine phosphorylation of pp68 by sorbitol was mediated through the
activation of the p42/44 or the p38 MAP kinase pathways, we examined
whether MAP kinase inhibitors could affect pp68 accumulation.
Adipocytes were preincubated with either DMEM alone, the
mitogen-activated protein kinase/extracellular signal-regulated kinase
kinase inhibitor PD 98059 (100 µM for 1 h), or with
the p38 MAP kinase inhibitor SB 203580 (20 µM for 30 min). The cells were then treated with 600 mM sorbitol for
15 min followed by the addition of 100 nM insulin for 5 min. The amount of pp68 in the LDM was visualized by phosphotyrosine
Western blot analysis. Fig. 5B illustrates that these
inhibitors had no effect on pp68 accumulation, even though they did
specifically inhibit the activation of these pathways by Western blot
analyses using phospho-specific antibodies (data not shown). Because we
are unaware of a specific inhibitor of the SAPK/JNK pathway, we cannot
address the importance of this pathway in enhancing the insulin-induced
phosphorylation of pp68.
The Elimination of Possible Candidate and Interacting
Proteins--
There are several known 68-70-kDa proteins that are
phosphorylated on tyrosine. By immunoprecipitating these proteins from LDM prepared from sorbitol- and insulin-treated adipocytes using commercially available antibodies followed by phosphotyrosine Western
blot analyses on the precipitated proteins, we eliminated the
possibility of pp68 being SHC, Src, Fyn, IRS-3, Syp, PTP1C, p62Dok,
Paxillin, or Sam68 (Table I). Using this
same procedure, we determined that pp68 does not interact with IRS-1,
PI 3-kinase, Glut 4-containing vesicles, RasGap, Fak, Cbl, Grb2, Pyk2,
Nck, Src, or Cas (Table I). In all cases we verified that the
commercial antibody did in fact immunoprecipitate the appropriate
protein (data not shown).
pp68 Is an RNA-binding Protein--
It has been reported that
insulin induces the tyrosine phosphorylation of a 70-kDa protein in A14
fibroblasts (26) that were pretreated with the phosphotyrosine
phosphatase inhibitor phenylarsine oxide (PAO). This protein is not
Sam68 but it does bind poly(U)-Sepharose. To determine whether pp68
binds to RNA, LDM containing pp68 were treated with RNase A for 2 h on ice prior to centrifugation at 200,000 × g. The
phosphotyrosine blot (Fig. 6A) revealed
that RNase treatment released pp68 but not Glut 4 from the LDM. To
further confirm that pp68 is an RNA-binding protein, we tested the
ability of pp68 to bind either poly(A)-Sepharose 4B, poly(U)-agarose,
or agarose alone. pp68 was first released from the LDM with 600 mM NaCl. After removing the insoluble material by
centrifugation, the salt concentration was diluted to 150 mM NaCl. After incubating pp68 with the RNA resins for
2 h, the samples were centrifuged, the pellets washed four times,
and phosphotyrosine Western blot analyses were then carried out on the
bound material. Fig. 6B illustrates that the majority of the
pp68 starting material bound to poly(A) and poly(U) resins but not to
agarose alone. Although these results indicate that pp68 binds RNA,
they do not address whether the binding is direct or through another
protein(s). In addition to pp68, the tyrosine-phosphorylated proteins
pp55 and pp75 that we observed in the LDM fraction of Fig. 1 also bound to RNA.
To address whether pp68 might be the same 70-kDa protein reported in
A14 fibroblasts (26), 3T3-L1 adipocytes were incubated with PAO for 15 min followed by the addition of insulin for 5 min. Phosphotyrosine
blots showed that a protein of 68 kDa accumulated in cells treated with
PAO and insulin (Fig. 7). In addition to pp68, LDM from both sorbitol- and PAO-treated adipocytes contained proteins of 55, 75, and 95 kDa that exhibited enhanced
insulin-stimulated tyrosine phosphorylation. Because PAO is a potent
phosphotyrosine phosphatase inhibitor and the same pattern of
insulin-stimulated tyrosine-phosphorylated proteins accumulated with
both PAO and sorbitol, this suggests that osmotic shock may inhibit a
phosphotyrosine phosphatase that leads to an increase in the
insulin-stimulated tyrosine phosphorylation of several LDM proteins,
especially pp68. The 95-kDa tyrosine-phosphorylated protein is probably
the Insulin mediates its biological effects by activating an intrinsic
tyrosine kinase upon binding of the hormone to specific cell surface
receptors (1). Tyrosine phosphorylation of cellular substrates such as
the IRS proteins (2), Gab-1 (27), p62DOK (28), and SHC (3) creates
docking sites for multiple downstream signaling molecules. In this
study we identified a downstream molecule in the insulin-signaling
pathway that resides in the Triton X-100 insoluble fraction of the LDM
of 3T3-L1 adipocytes and binds to RNA. The LDM fraction is enriched in
endosomes, Golgi, and insulin responsive Glut 4-containing vesicles
(15). In addition to pp68, other insulin signaling molecules, such as
IRS-1, PI 3-kinase, and SHC, have been localized to the nonionic
detergent-resistant fraction of the LDM (17). Hill et al.
(29) identified 12 insulin-stimulated phosphoproteins in the LDM of
3T3-L1 adipocytes by combining metabolic labeling, subcellular
fractionation, and two-dimensional gel electrophoresis. The majority of
these proteins are also present in the detergent insoluble fraction,
including a protein with a molecular mass of 66 kDa. It was not
reported, however, whether this protein is phosphorylated on tyrosine.
Because pp68 did not associate with IRS-1, PI 3-kinase, or SHC, this
suggests that pp68 resides in a different compartment in the LDM.
Triton X-100 insolubility is a known characteristic of the actin
cytoskeleton, and long filamentous structures that resemble
cytoskeletal elements have been observed by electron microscopy in the
detergent insoluble fraction of the LDM (17). However, the observation
that treatment of 3T3-L1 adipocytes with actin or
tubulin-depolymerizing agents failed to affect the accumulation of pp68
in the LDM (Fig. 4B) suggests that pp68 is not associated
with the membrane skeleton.
pp68 is not the first reported RNA-binding protein that is
phosphorylated on tyrosine. Sam68 is a 68-kDa RNA-binding protein that
is a substrate of the SRC tyrosine kinase during mitosis (30, 31). Upon
phosphorylation, this protein binds to several SH3 and SH2
domain-containing signaling molecules such as Grb2 (32), phospholipase
C Osmotic stress enhanced the insulin-stimulated tyrosine phosphorylation
of pp68 10-fold (Fig. 1). Although hypertonic shock activated both the
p42/44 and the p38 MAP kinase pathways (Fig. 5A), inhibitors
of these pathways did not affect pp68 accumulation, suggesting that
induction of these pathways is not responsible for the enhancement of
insulin-stimulated tyrosine phosphorylation of pp68. Other types of
cellular stress, such as oxidative stress, heat shock, depletion of
potassium, and inhibition of the Na+/K+-ATPase
did not modulate insulin-induced tyrosine phosphorylation of pp68. PAO
is a known tyrosine phosphatase inhibitor. Inhibition of two
phosphotyrosine phosphatases, HA1 and HA2, by PAO results in the
insulin-stimulated tyrosine phosphorylation of a 15-kDa fatty
acid-binding protein (38). In addition, PAO blocks insulin-induced RAS
activation by inhibiting the phosphotyrosine phosphatase Syp (39).
Because the same pattern of insulin-stimulated tyrosine phosphorylated
proteins, including pp68, accumulated in the LDM with both PAO and
sorbitol treatment (Fig. 7), this suggests that osmotic shock may
inhibit a phosphotyrosine phosphatase that leads to an increase in
pp68. This would explain the increase in ligand-induced tyrosine
phosphorylation of the insulin receptor in the PM fraction even though
the amount of receptor did not change with hypertonic shock.
Furthermore, inhibition of a phosphatase could result in an increase in
the number of phosphorylated proteins. For example, treatment of cells
with the serine phosphatase inhibitor, calyculin A, was shown to
increase the basal phosphorylation of both AKT (11) and p70S6 kinase
(12). Therefore, the increase in tyrosine phosphorylation of several
proteins in the 115-130 kDa and 50-70 kDa range observed when
adipocytes were treated with sorbitol alone (Fig. 1 (10)) may be due at
least in part to an inhibition of phosphotyrosine phosphatase(s) rather
than a stimulation of phosphotyrosine kinase(s).
The identity of pp68 remains elusive. We have eliminated a number of
known 65-70-kDa tyrosine-phosphorylated proteins (Table I) as being
pp68. Recently, PAO and insulin were shown to induce the tyrosine
phosphorylation of a 70-kDa protein in A14 fibroblasts that could bind
poly(U)-RNA (26). This protein was neither Sam68 nor heterogeneous
nuclear ribonucleoprotein K. Because the identity of this 70-kDa
protein has not been reported, we cannot address whether pp68 and pp70
are the same protein. In contrast to pp70, pp68 in the LDM did not
associate with RasGAP or Grb2. We cannot rule out, however, that pp68
that resides in another compartment like the cytosol binds these SH2
and SH3 domain-containing proteins. In fact, all of the experiments on
pp70 were done using total cell lysates as opposed to a LDM fraction,
and osmotic shock was never used. pp68 has been purified to
homogeneity, and although our initial attempts were unsuccessful, we
are currently in the process of purifying enough material to obtain
sequence information. Based on the elimination of known proteins and on
the time and insulin concentration dependences of phosphorylation, pp68
could be a novel substrate of the insulin receptor tyrosine kinase
whose ability to bind RNA may dictate its physiological function.
*
This work was supported in part by National Institutes of
Health Grants DK38495 and DK50332 and by the Diabetes Research and Training Center at the Washington University Medical School.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, April 11, 2000, DOI 10.1074/jbc.M001937200
The abbreviations used are:
IRS-1, insulin
receptor substrate-1;
SH, Src homology;
PI 3-kinase, phosphatidylinositol 3-kinase;
LDM, low density microsomes;
poly(A), polyadenylic acid;
poly(U), polyuridylic acid;
DMEM, Dulbecco's
modified Eagle's medium;
MAP, mitogen-activated protein;
SAPK, stress-activated protein kinase;
JNK, c-Jun NH2-terminal
kinase;
PM, plasma membrane;
PAO, phenylarsine oxide.
A Novel 68-kDa Adipocyte Protein Phosphorylated on Tyrosine in
Response to Insulin and Osmotic Shock*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (81K):
[in a new window]
Fig. 1.
Subcellular localization of insulin and
osmotic shock-stimulated tyrosine-phosphorylated proteins in 3T3-L1
adipocytes. 3T3-L1 adipocytes were incubated for 15 min in the
presence or absence of 100 nM wortmannin (W).
Cells were then treated for 30 min with either DMEM alone
(B) or DMEM supplemented with 100 nM insulin
(I), 600 mM sorbitol (S), or the
combination of sorbitol and insulin (S + I). Adipocytes were
then washed three times with ice-cold phosphate-buffered saline,
homogenized, and fractionated by differential centrifugation (see
"Experimental Procedures"). PM, cytosol, high density microsomes
(HDM), and LDM fractions were separated by
SDS-polyacrylamide gel electrophoresis (50 µg of protein),
immunoblotted, incubated with antiphosphotyrosine primary and
125I-labeled secondary antibodies, and then visualized by
autoradiography.

View larger version (47K):
[in a new window]
Fig. 2.
The time course and concentration curve of
insulin-stimulated tyrosine phosphorylation of pp68. 3T3-L1
adipocytes were preincubated for 15 min with 600 mM
sorbitol in both experiments. 100 nM insulin was added for
varying periods of time to measure the rate of insulin-stimulated pp68
phosphorylation. Different concentrations of insulin were added for 5 min in determining the hormone concentration dependence. After
treatment, phosphotyrosine Western blot analyses were conducted on the
LDM fraction prepared by differential centrifugation (see
"Experimental Procedures"). Autoradiograms were quantitated by
phosphoimaging. Quantitative data represent the mean ± S.E. of
three independent experiments.

View larger version (13K):
[in a new window]
Fig. 3.
The effect of osmotic shock on
insulin-stimulated pp68 tyrosine phosphorylation was rapidly
reversible. 100 nM insulin was added for 5 min to
adipocytes that were pretreated with 600 mM sorbitol for 15 min. Cells were then washed and incubated for varying periods of time
in medium containing 100 nM insulin in the absence or
presence of sorbitol. The amount of tyrosine-phosphorylated pp68 in the
isolated LDM was quantitated from phosphotyrosine Western blots.
Because the quantity of pp68 may vary with time without the removal of
sorbitol (see Fig. 2), the amount of pp68 that remained after the
sorbitol washout was normalized to the amount of pp68 that remained for
the same period of time in the presence of sorbitol. Each data point
represents the mean ± S.E. of three independent
experiments.

View larger version (41K):
[in a new window]
Fig. 4.
pp68 is a peripheral membrane protein that
associates with the Triton X-100 insoluble fraction of the LDM.
A, 50 µg of LDM, prepared from adipocytes that were
treated with 600 mM sorbitol for 15 min and then stimulated
with insulin for 5 min, were incubated in buffer containing 600 mM NaCl or 1% Triton X-100 for 30 min at 4 °C. Soluble
(S) and insoluble (P) material were isolated
after centrifugation for 1 h at 200,000 × g. The
distribution of pp68 and Glut 4 in the various fractions were
determined by Western blots using phosphotyrosine and Glut 4 antibodies, respectively. B, 3T3-L1 adipocytes were
incubated in DMEM alone for 3 h (CONTROL) or treated
with 2 or 10 µM cytochalasin D (CD) for 3 h, 2 µM latrunculinB (LB) for 3 h, 3.3 µM nocodazole (NOC) for 3 h, or 33 µM nocodozole for 1 h. 600 mM sorbitol
was then added for 15 min followed by a 5-min stimulation with 100 nM insulin. Phosphotyrosine blots were carried out on LDM
isolated from the various treated cells.

View larger version (42K):
[in a new window]
Fig. 5.
The p42/44 and the p38 MAP kinase pathways
are not involved in the enhancement by osmotic shock on the
insulin-stimulated tyrosine phosphorylation of pp68. A,
3T3-L1 adipocytes were incubated for 15 min in the presence or absence
of 100 nM wortmannin (W). Cells were then
treated for 30 min with either DMEM alone (B) or DMEM
supplemented with 100 nM insulin (I), 600 mM sorbitol (S), or the combination of sorbitol
and insulin (S + I). Western blot analyses were carried out
on 50 µg of whole cell lysates using phospho-specific antibodies
directed against p42/44 MAP kinase, p38 MAP kinase, or SAPK/JNK.
B, adipocytes were incubated in DMEM alone
(CONTROL), the mitogen-activated protein
kinase/extracellular signal-regulated kinase kinase inhibitor PD 98059 (100 µM for 1 h), or the p38 MAP kinase inhibitor SB
203580 (20 µM for 30 min). 600 mM sorbitol
was then added for 15 min followed by 100 nM insulin for 5 min. Phosphotyrosine blots were carried out on LDM isolated from the
various treated cells.
Candidate and interacting proteins eliminated by negative
immunoprecipitation results

View larger version (43K):
[in a new window]
Fig. 6.
pp68 binds RNA. A, 75 µg of
LDM, prepared from cells treated with 600 mM sorbitol for
15 min and then 100 nM insulin for 5 min, were incubated in
the presence or absence of 0.4 mg/ml RNase A for 2 h on ice.
Soluble (S) and insoluble (P) material were
isolated after centrifugation for 1 h at 200,000 × g. The distribution of pp68 and Glut 4 in the various
fractions was determined by Western blots using phosphotyrosine and
Glut 4 antibodies, respectively. B, 75 µg of LDM, prepared
from cells treated with 600 mM sorbitol for 15 min and then
100 nM insulin for 5 min, were incubated in 600 mM NaCl for 30 min. After removing the insoluble material
by centrifugation at 200,000 × g for 1 h, the
salt concentration was diluted to 150 mM NaCl. Samples were
then incubated for 2 h at 4 °C with 50 µl of agarose, 50 µl
of poly(A)-Sepharose 4B, or 50 µg of poly(U)-agarose. After washing
the pellets four times, phosphotyrosine Western blot analyses were
carried out on the bound material. The TOTAL was a sample
that was treated with high salt, centrifuged, diluted, but not
incubated with the resins.
-subunit of the insulin receptor. Because the identity of the
70-kDa protein in A14 cells has not been reported, we cannot prove that
pp68 is the same protein even though it appears to accumulate in the presence of PAO and insulin. However, unlike pp70 from A14 fibroblasts, pp68 does not bind to RasGAP or Grb2 (Table I). To examine whether other types of cellular stress can modulate insulin-induced tyrosine phosphorylation of pp68, we determined what effect oxidative stress, heat shock, potassium depletion, and inhibition of the
Na+/K+-ATPase had on the accumulation of pp68.
3T3-L1 adipocytes were treated with either H2O2
for 15 min, heated to 43 °C for 90 min, depleted of K+
for 90 min, or incubated with 1 mM ouabain for 1 h
prior to the addition of insulin for 5 min. The amount of pp68 in the
LDM fraction was then analyzed from phosphotyrosine Western blots. None
of these other conditions affected the level of pp68 (data not
shown).

View larger version (88K):
[in a new window]
Fig. 7.
LDM from phenylarsine oxide- and
insulin-treated 3T3-L1 adipocytes contain a 68-kDa
phosphotyrosine-containing protein. 3T3-L1 adipocytes were treated
for 15 min with DMEM alone (CON) or DMEM containing 600 mM sorbitol (SORB) or 35 µM PAO.
100 nM insulin was added or not for an additional 5 min.
Phosphotyrosine Western blots were carried out on LDM prepared by
differential centrifugation (see "Experimental Procedures").
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-1 (32), Nck (33), and Cbl (34). The RNA-binding activity is
inhibited upon tyrosine phosphorylation (35). Sam68 and pp68 appear to
be different proteins based upon the failure to immunoprecipitate pp68
with Sam68-specific antibodies and on the ability of
tyrosine-phosphorylated pp68 to bind RNA. A second 68-kDa RNA-binding
protein that can be phosphorylated on tyrosine is heterogeneous nuclear
ribonucleoprotein K (36). This protein, which recruits a diverse group
of molecules that includes RNA, DNA, Vav, transcription repressors, and
inducible kinases, has been implicated in transcription, RNA
processing, and translation (37). Treatment with
H2O2/vanadate induces the tyrosine
phosphorylation of K protein in both cell culture and in mouse liver
(36). Tyrosine phosphorylation was shown to enhance subsequent serine
phosphorylation by protein kinase C as well as increase the association
of K protein with Lck and the proto-oncoprotein Vav. K protein binds
preferentially to poly(C) but not to poly(U)-RNA. Tyrosine
phosphorylation inhibits the protein-RNA interaction in a similar
manner to Sam68. Based on the observations that tyrosine-phosphorylated pp68 bound efficiently to poly(U)-RNA (Fig. 6), that pp68 did not
accumulate in adipocytes with H2O2 and insulin,
and that PAO and insulin could stimulate pp68 (Fig. 7) but not K
protein (26) tyrosine phosphorylation, pp68 is probably not
heterogeneous nuclear ribonucleoprotein K.
![]()
FOOTNOTES
To whom correspondence should be addressed: Dept. of Cell Biology
and Physiology, Washington University School of Medicine, 660 S. Euclid
Ave., St. Louis, MO 63110. Tel.: 314-362-4160; Fax: 314-362-7463;
E-mail: mike@cellbio.wustl.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Cheatham, B.,
and Kahn, C. R.
(1995)
Endocr. Rev.
16,
117-142
2.
White, M. F.
(1998)
Mol. Cell. Biochem.
182,
3-11
3.
Pelicci, G. L.,
Lanfrancone, L.,
Grignani, F.,
McGlade, J.,
Cauallo, F.,
Forni, G.,
Nicoletti, I.,
Pawson, T.,
and Pelicei, P. G.
(1992)
Cell
70,
93-104
4.
Sun, X. J.,
Crimmins, D. L.,
Myers, M. G. J.,
Miralpeix, M.,
and White, M. F.
(1993)
Mol. Cell. Biol.
13,
7418-7428
5.
Sun, X. J.,
Pons, S.,
Asano, T.,
Myers, M. G. F., Jr.,
Glasheen, E.,
and White, M. F.
(1996)
J. Biol. Chem.
271,
10583-10587
6.
Pons, S.,
Asano, T.,
Glasheen, E.,
Miralpeix, M.,
Zhang, Y.,
Fisher, T. L.,
Myers, M. G. J.,
Sun, X. J.,
and White, M.
(1995)
Mol. Cell. Biol.
15,
4453-4465
7.
Shephard, P. R.,
Withers, D. J.,
and Siddle, K.
(1998)
Biochem. J.
333,
471-490
8.
Skolnik, E. Y.,
Lee, C. H.,
Batzer, A.,
Vicentini, L. M.,
Zhou, M.,
Daly, R.,
Myers, M. J.,
Backer, J. M.,
Ulrich, A.,
White, M. F.,
and Schlessinger, J.
(1993)
EMBO J.
12,
1929-1936
9.
Li, N.,
Batzer, A.,
Daly, R.,
Yajnik, V.,
Skolnik, E.,
Chardin, P.,
Bar-Sagi, D.,
Margolis, B.,
and Schlessinger, J.
(1993)
Nature
363,
85-88
10.
Chen, D.,
Elmendorf, J. S.,
Olson, A. L.,
Li, X.,
Earp, H. S.,
and Pessin, J. E.
(1997)
J. Biol. Chem.
272,
27401-27410
11.
Chen, D.,
Fucini, R. V.,
Olson, A. L.,
Hemmings, B. A.,
and Pessin, J. E.
(1999)
Mol. Cell. Biol.
19,
4884-4694
12.
Parrott, L. A.,
and Templeton, D. J.
(1999)
J. Biol. Chem.
274,
24731-24736
13.
Tordjman, K. M.,
Leingang, K. A.,
James, D. E.,
and Mueckler, M. M.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
7761-7765
14.
Piper, R. C.,
Hess, L. J.,
and James, D. E.
(1991)
Am. J. Physiol.
260,
C570-C580
15.
Simpson, I. A.,
Yver, D. R.,
Hissin, P. J.,
Wardzala, L. J.,
Darnieli, E.,
Salans, L. B.,
and Cushman, S. W.
(1983)
Biochim. Biophys. Acta
763,
393-407
16.
Kelly, K. L.,
and Ruderman, N. B.
(1993)
J. Biol. Chem.
268,
4391-4398
17.
Clark, S. F.,
Martin, S.,
Carozzi, A. J.,
Hill, M. M.,
and James, D. E.
(1998)
J. Cell Biol.
140,
1211-1225
18.
Madoff, D. H.,
Martensen, T. M.,
and Lane, M. D.
(1988)
Biochem. J.
252,
7-15
19.
White, M. F.,
Maron, R.,
and Kahn, C. R.
(1985)
Nature
318,
183-186
20.
Han, J.,
Lee, J. D.,
Bibbs, L.,
and Ulevitch, R. J.
(1994)
Science
265,
808-811
21.
Matsuda, S.,
Kawasak, H.,
Moriguchi, T.,
Gotoh, Y.,
and Nishida, E.
(1995)
J. Biol. Chem.
270,
12781-12786
22.
Boulton, T. G.,
Nye, S. H.,
Robbins, D. J., IP, N. Y.,
Radziejewska, E.,
Morgenbesser, S. D.,
DePinho, R. A.,
Panayotatos, N.,
Cobb, M. H.,
and Yancopoulos, G. D.
(1991)
Cell
65,
663-675
23.
Suga, J.,
Yoshimasa, Y.,
Yamada, K.,
Yamamoto, Y.,
Inoue, G.,
Okamoto, M.,
Hayashi, T.,
Shigemoto, M.,
Kosaki, A.,
Kuzuya, H.,
and Nakao, K.
(1997)
Diabetes
46,
735-741
24.
Wojtaszewski, J. F. P.,
Lynge, J.,
Jakobsen, A. B.,
Goodyear, L. J.,
and Richter, E. A.
(1999)
Am. J. Physiol.
277,
E724-E732
25.
Sweeney, G.,
Somwar, R.,
Ramlal, T.,
Volchuk, A.,
Ueyama, A.,
and Klip, A.
(1999)
J. Biol. Chem.
274,
10071-10078
26.
Medema, J. P.,
Pronk, G. J.,
de Vries-Smits, A. M. M.,
Clark, R.,
McCormick, F.,
and Bos, J. L.
(1996)
Cell Growth Differ.
7,
543-550
27.
Holgado-Madruga, M.,
Emlet, D. R.,
Moscatello, D. K.,
Godwin, A. K.,
and Wong, A. J.
(1996)
Nature
379,
560-563
28.
Yamanashi, Y.,
and Baltimore, D.
(1997)
Cell
88,
205-211
29.
Hill, M. M.,
Clark, S. F.,
and James, D. E.
(1997)
Electrophoresis
18,
2629-2637
30.
Taylor, S. J.,
and Shalloway, D.
(1994)
Nature
368,
867-871
31.
Fumagalli, S.,
Totty, N.,
Hsuan, J. J.,
and Courtneidge, S. A.
(1994)
Nature
368,
871-874
32.
Richard, S., Yu, D.,
Bloumer, K. J.,
Hausladen, D.,
Olszowy, M. W.,
Connelly, P. A.,
and Shaw, A. S.
(1995)
Mol. Cell. Biol.
15,
186-197
33.
Lawe, D. C.,
Hahn, C.,
and Wong, A. J.
(1997)
Oncogene
14,
223-231
34.
Fusaki, N.,
Iwamatsu, A.,
Iwahima, M.,
and Fujisawa, J.
(1997)
J. Biol. Chem
272,
6214-6219
35.
Wang, L. L.,
Richard, S.,
and Shaw, A. S.
(1995)
J. Biol. Chem.
270,
2010-2013
36.
Ostrowski, J.,
Schullery, D. S.,
Denisenko, O. N.,
Higaki, Y.,
Watts, J.,
Aebersold, R.,
Stempka, L.,
Gschwendt, M.,
and Bomsztyk, K.
(2000)
J. Biol. Chem.
275,
3619-3628
37.
Bomsztyk, K.,
Van Seuningen, I.,
Suzuki, H.,
Denisenko, O.,
and Ostrowski, J.
(1997)
FEBS Lett.
403,
113-115
38.
Liao, K.,
Hoffman, R. D.,
and Lane, M. D.
(1991)
J. Biol. Chem.
266,
6544-6553
39.
Noguchi, T.,
Matozaki, T.,
Horita, K.,
Fujioka, Y.,
and Kasuga, M.
(1994)
Mol. Cell. Biol.
14,
6674-6682
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Cho, S. M. Park, T. D. Kim, J. H. Kim, K.-T. Kim, and S. K. Jang BiP Internal Ribosomal Entry Site Activity Is Controlled by Heat-Induced Interaction of NSAP1 Mol. Cell. Biol., January 1, 2007; 27(1): 368 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bannai, K. Fukatsu, A. Mizutani, T. Natsume, S.-i. Iemura, T. Ikegami, T. Inoue, and K. Mikoshiba An RNA-interacting Protein, SYNCRIP (Heterogeneous Nuclear Ribonuclear Protein Q1/NSAP1) Is a Component of mRNA Granule Transported with Inositol 1,4,5-Trisphosphate Receptor Type 1 mRNA in Neuronal Dendrites J. Biol. Chem., December 17, 2004; 279(51): 53427 - 53434. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Pesesse, K. Choi, T. Zhang, and S. B. Shears Signaling by Higher Inositol Polyphosphates: SYNTHESIS OF BISDIPHOSPHOINOSITOL TETRAKISPHOSPHATE ("InsP8") IS SELECTIVELY ACTIVATED BY HYPEROSMOTIC STRESS J. Biol. Chem., October 15, 2004; 279(42): 43378 - 43381. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ibarrola, H. Molina, A. Iwahori, and A. Pandey A Novel Proteomic Approach for Specific Identification of Tyrosine Kinase Substrates Using [13C]Tyrosine J. Biol. Chem., April 16, 2004; 279(16): 15805 - 15813. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Hresko and M. Mueckler Identification of pp68 as the Tyrosine-phosphorylated Form of SYNCRIP/NSAP1. A CYTOPLASMIC RNA-BINDING PROTEIN J. Biol. Chem., July 5, 2002; 277(28): 25233 - 25238. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, V. K. Randhawa, N. Patel, M. Hayashi, and A. Klip Hyperosmolarity Reduces GLUT4 Endocytosis and Increases Its Exocytosis from a VAMP2-independent Pool in L6 Muscle Cells J. Biol. Chem., June 15, 2001; 276(25): 22883 - 22891. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals |